对帕金森病干预措施的响应者的特征:一个覆盖范围的系统性审查
Sidney T Baudendistel1, Gammon M Earhart1,2,3
1Program in Physical Therapy, Washington University School of Medicine, St. Louis, USA.
Neurodegenerative disease management
|April 30, 2025
概括
在帕金森病干预中识别响应者是个性化运动功能治疗的关键. 根据干预类型的特征有所不同,包括神经调节,药物和物理治疗.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病显著影响运动功能.
- 识别响应干预的患者子组对于治疗优化至关重要.
- 目前的文献缺乏对不同干预类型的响应者特征的全面概述.
研究的目的:
- 系统地审查和识别那些对帕金森病中向运动功能的干预措施做出反应的个体的特征.
- 根据干预方式区分响应者个人资料.
主要方法:
- 使用关键词如"帕金森病"和"响应者"进行系统的文献搜索,并补充了更广泛的术语.
- 干预措施分为神经调节,制药,物理和安慰剂组.
- 从确定的研究中提取和合成120个特征.
主要成果:
- 神经调节反应者:较年轻的发病率,利沃多巴反应性,较大的日常生活困难.
- 药物响应者:在诊断时年龄较小.
- 身体干预反应者:平衡较差,平衡信心降低,认知能力下降.
结论:
- 响应者分析为定制帕金森病运动症状治疗提供了宝贵的见解.
- 尽管有局限性,但这种方法促进了帕金森病的个性化医疗.
- 需要进一步的研究来解决文献上的差距,并完善应答者识别.
相关概念视频
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Parkinson's Disease: Overview
308
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
308
Psychosis: Goals of Pharmacotherapy
95
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
95
Personality Disorders: Paranoid and Schizoid
8
Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...
Paranoid Personality Disorder
Paranoid personality disorder is...
8
Drug Therapy
28
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
28
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K


